Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials
NCT03943082 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 252
Last updated 2021-11-16
Summary
This trial studies how well a follow-up phone call regarding financial reimbursement program (FRP) works in improving cancer patients' access to therapeutic cancer clinical trials. Follow-up phone call intervention regarding FRP may improve recruitment of cancer patients to cancer therapeutic clinical trials.
Conditions
- Malignant Neoplasm
- Hematopoietic and Lymphoid Cell Neoplasm
Interventions
- BEHAVIORAL
-
Cancer Educational Materials
Receive FRP brochure
- OTHER
-
Follow-Up Care
Receive follow-up phone call
- BEHAVIORAL
-
Questionnaire
Ancillary studies
Sponsors & Collaborators
-
Lazarex Cancer Foundation
collaborator UNKNOWN -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Hala Borno, MD · University of California, San Francisco
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 7 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-08
- Primary Completion
- 2021-10-26
- Completion
- 2021-10-26
Countries
- United States
Study Locations
More Related Trials
-
Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers
NCT06798922 ·Status: RECRUITING ·Phase: PHASE3
-
Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers
NCT06918951 ·Status: RECRUITING ·Phase: NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
NCT03812289 ·Status: TERMINATED ·Phase: NA
-
A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy
NCT00608751 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors
NCT01470365 ·Status: COMPLETED ·Phase: PHASE1
-
Telehealth in Improving Quality of Life in Patients During Post Radiation Therapy Visits
NCT02751580 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer
NCT00002484 ·Status: COMPLETED ·Phase: PHASE1
-
Remote Activity Monitored by Fitbit Charge 3 in Investigating Daily Step and Sleep Data in Participants With Head and Neck Cancer Undergoing Radiation Therapy
NCT03489252 ·Status: COMPLETED ·Phase: NA
-
Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma
NCT00014326 ·Status: TERMINATED ·Phase: PHASE3
-
Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
NCT06014827 ·Status: RECRUITING ·Phase: PHASE2
-
Prospective Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck Cancer
NCT02003482 ·Status: COMPLETED
-
Radiation Therapy in Treating Patients With Head and Neck Cancer
NCT00021125 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Optical Imaging With Light From Radiotracers in Cancer Patients
NCT03484884 ·Status: ACTIVE_NOT_RECRUITING
-
Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
NCT01345851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
NCT02439008 ·Status: TERMINATED ·Phase: NA
-
Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
NCT01055197 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Radiation Therapy in Treating Patients With Liver Metastases
NCT00938457 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.
NCT04823377 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation
NCT06110572 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
NCT00533949 ·Status: COMPLETED ·Phase: PHASE3
-
Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma
NCT00310167 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease
NCT01427322 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
NCT05793151 ·Status: RECRUITING ·Phase: NA
-
Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19
NCT04357574 ·Status: ENROLLING_BY_INVITATION
-
19F Thoracic Radiotherapy for Lung Cancer
NCT03315065 ·Status: COMPLETED ·Phase: EARLY_PHASE1